MESA, Ariz., March 29, 2011 /PRNewswire/ -- A woman's face tells her story but sometimes showing a few less chapters is desirable.  Even with surgery, fillers, lasers and more, the quest continues for new ways to keep skin looking its best at any age.  According to the new Face Forward survey commissioned by Ulthera® (the manufacturer of the first-and-only energy-based device for aesthetics cleared by the FDA with a non-invasive lift indication), 83 percent of women admitted they would forego some of their favorite indulgences for three months, including: dining out, shopping, salon visits–even sex–for a more youthful face.  The Ulthera Face Forward survey was conducted by Kelton Research to examine the features women are most concerned with and how motivated they are to address these concerns.  

The Ulthera Face Forward survey polled 515 women ages 18 and over across the United States.  Findings reveal that over four-in-five women (83 percent) agreed to give up an indulgence for three months in favor of having a more youthful looking face.  Of those women:

• Who needs to eat? Nearly half said they would forego restaurants (49 percent).
• Bad hair day? Okay. Forty-six percent of women would stop salon visits to have their hair or nails done.
• Not tonight, honey. Nearly one-out-of-three (32 percent) said they would give up sex!
• Face over fashion! Over one-third (35 percent) would even forego shopping.

The survey results conclude that more than three out of four women (78 percent) are distressed by at least one aging feature above their chest.

• Ninety percent of women, ages 45-54, have at least one bothersome age-related feature on their face and neck.
  
  

  SOURCE Ulthera, Inc. Copyright©2010 PR Newswire. All rights reserved

  0 GOOD

  
  Page: 1 2 3
  Related medicine technology :
  
  1. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
  2. A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share in the Obesity Drug Market
  3. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
  4. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
  5. For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastins Dominance in Europe
  6. An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
  7. Three in Ten Americans Would Use Their Cell Phone to Track Personal Health, Finds PricewaterhouseCoopers
  8. Sermo Study Shows 63% of Physicians Would Utilize New Gout Treatments
  9. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
  10. Bi-Partisan Legislation Introduced Would Repeal Controversial Medicare Competitive Bidding Requirements for Home Medical Equipment
  11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
  

• AIDS/HIV
• Bioinformatics
• Biotechnology
• Biochemistry
• Cancer
• Cell Biology
• Developmental Biology
• Ecology
• Environment
• Evolution
• Food Technology
• Gene
• Genetics
• Genomics
• Health/Medicine
• Immunology
• Microarray
• Microbiology
• Molecular
• Marine Biology
• Nanobiotechnology
• Neurobiology
• Plant Sciences
• Stem Cell
• Systems Biology
• Virus
• Women Health

• Abortion
• Aches
• ADHD
• Addiction
• Alcohol
• Allergy
• Alternative Medicine
• Alzheimer's Dementia
• Anxiety/Stress
• Arthritis
• Autism
• Bacteria
• Blood
• Bird Flu/Avian Flu
• Bones
• Breast Cancer
• Cancer
• Cardiovascular
• Cervical Cancer
• Chikungunya
• Cholesterol
• Clinical Trials
• Colorectal Cancer
• Conferences
• Crohn's
• Cystic Fibrosis
• Dengue
• Dentistry
• Depression
• Diabetes
• Drug
• Eating Disorders
• Education
• Epilepsy
• Erectile Dysfunction
• Eye Health/Blindness
• Fertility
• Flu/Cold
• GastroIntestinal
• Genetics
• Gout
• Headache/Migraine
• Hearing/Deafness
• HIV/AIDS
• Huntington's Disease
• Hypertension
• Immune System/Vaccines
• Insurance
• Infectious Diseases
• Irritable-Bowel Syndrome
• Internet
• Leukemia
• Lifestyle
• Liver Disease/Hepatitis
• Lung Cancer
• Lupus
• Mad Cow Disease
• Medical Devices
• Medical Students/Training
• Medicare/Medicaid
• Medico
• Men's health
• Mental Health
• MRI/Ultrasound
• MRSA/Drug Resistance
• Multiple Sclerosis
• Muscular Dystrophy
• Neurology
• Nursing
• Nutrition/Diet
• Obesity/Weight Loss
• Pain/Anesthetics
• Parkinson's Disease
• Pediatrics/Children's Health
• Pharma/Biotech Industry
• Pharmacy/Pharmacists
• Pregnancy
• Premature
• Prostate
• Psychology/Psychiatry
• Rehabilitation
• Respiratory/Asthma
• SARS
• Schizophrenia
• Seniors/Aging
• Sexual Health
• Sleep/Sleep Disorders
• Smoking
• Statins
• Stem Cell Research
• Stroke
• Surgery
• Transplants/Organ Donations
• Viruses
• Water - Air Quality
• Women's Health